Ann Coloproctol.  2015 Jun;31(3):84-91. 10.3393/ac.2015.31.3.84.

Expression of the Cancer Stem Cell Markers CD44 and CD133 in Colorectal Cancer: An Immunohistochemical Staining Analysis

• Hong I
• Hong SW
• Chang YG
• Lee WY
• Lee B
• Kang YK
• Kim YS
• Paik IW
• Lee H

• KMID: 2169728
• DOI: http://doi.org/10.3393/ac.2015.31.3.84

Abstract

PURPOSE
The aim of this study was to assess the expressions of CD44 and CD133 in colorectal cancer tissue by using immunohistochemical staining and to analyze the clinical significance of the expressions related to other clinicopathological data and survival results.
METHODS
One hundred sixty-two patients with a biopsy-proven colorectal adenocarcinoma who were operated on between January 1998 and August 2004 were enrolled in this study. Immunohistochemical staining for CD44 and CD133 was performed on primary colorectal cancer tissue, metastatic lymph nodes, and synchronous and metachronous metastatic tumor tissues if available.
RESULTS
CD44 expression was stronger in the primary tumor than in metastatic lymph nodes (P < 0.001), and CD133 expression tended to be stronger in primary tumor than in metastatic lymph nodes (P = 0.057). No significant correlation was found between the CD44 and the CD133 expressions. The cases with recurrence showed low expression of CD44 (P = 0.017). CD133 expression was lower in cases with elevated CA 19-9 serum levels (P = 0.028) and advanced T stage (P = 0.038). Multivariate analysis proved that low expression of CD44 was an independent prognosis factor for short disease-free survival (P = 0.028).
CONCLUSION
Low CD44 expression was correlated with increased tumor recurrence and short disease-free survival, and low CD133 expression was associated with advanced tumor stage. We suggest that further studies be performed to evaluate whether the immunohistochemical method for determining the CD44 and the CD133 expressions is appropriate for exploring cancer stem-cell biology in patients with colorectal cancer.

Keyword

Colorectal neoplasms; CD40 antigens; CD133 antigen; Stem cell

MeSH Terms

Adenocarcinoma
Antigens, CD40
Biology
Colorectal Neoplasms*
Disease-Free Survival
Humans
Lymph Nodes
Multivariate Analysis
Neoplastic Stem Cells*
Prognosis
Recurrence
Stem Cells
Antigens, CD40